Concomitant BCR-ABL1 positive chronic myelogenous leukemia emerging in a patient with MPL W515L associated primary myelofibrosis by Juan C. Gomez-Gelvez, MD, Elena Ivan, MD, Bryan L. Betz, PhD, Megan S. Lim, MD, PhD

Subjects: Get full text

Imatinib independent aberrant methylation of NOV/CCN3 in chronic myelogenous leukemia patients: a mechanism upstream of BCR-ABL1 function? by Mousa Vatanmakanian, Mahmood Tavallaie, Shirin Ghadami

Subjects: Get full text

Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia by Hyacinthe Johnson-Ansah, Benjamin Maneglier, Françoise Huguet, Laurence Legros, Martine Escoffre-Barbe, Martine Gardembas, Pascale Cony-Makhoul, Valérie Coiteux, Laurent Sutton, Wajed Abarah, Camille Pouaty, Jean-Michel Pignon, Bachra Choufi, Sorin Visanica, Bénédicte Deau, Laure Morisset, Emilie Cayssials, Mathieu Molimard, Stéphane Bouchet, François-Xavier Mahon, Franck Nicolini, Philippe Aegerter, Jean-Michel Cayuela, Marc Delord, Heriberto Bruzzoni-Giovanelli, Philippe Rousselot

Subjects: Get full text

Chloroma of the Testis After Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report by Shih-Wen Hu, Sheau-Fang Yang, Chee-Yin Chai

Subjects: Get full text

Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in mice. by Kiyoko Yamamoto, Shinobu Tsuzuki, Yosuke Minami, Yukiya Yamamoto, Akihiro Abe, Koichi Ohshima, Masao Seto, Tomoki Naoe

“…Patients in the chronic phase (CP) of chronic myelogenous leukemia (CML) have been treated successfully following the advent of ABL kinase inhibitors, but once they progress to the blast crisis (BC) phase the prognosis becomes dismal. …”
Get full text

Immunoglobulin D multiple myeloma, plasma cell leukemia and chronic myelogenous leukemia in a single patient treated simultaneously with lenalidomide, bortezomib, dexamethasone and imatinib by Naveed Ali, Peter V. Pickens, Herbert E. Auerbach

Subjects: Get full text

Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells by Sun-Hyung Ha, Fansi Jin, Choong-Hwan Kwak, Fukushi Abekura, Jun-Young Park, Nam Gyu Park, Young-Chae Chang, Young-Choon Lee, Tae-Wook Chung, Ki-Tae Ha, Jong-Keun Son, Hyeun Wook Chang, Cheorl-Ho Kim

“…However, the anti-cancer effect of Jellyfish extract has not yet been examined. We used chronic myelogenous leukemia K562 cells to evaluate the mechanisms of anti-cancer activity of hexane extracts from Nomura’s jellyfish in vitro. …”
Get full text

Optimal response to imatinib therapy in a case of chronic myeloid leukemia with a concurrent loss of distal 22q by Bayan Alqahtany, Fatma S Alqahtani, Osamah Khojah, Abdurahman Almaeen, Aamer Aleem

Subjects: Get full text

Sudden visual loss as an initial manifestation of chronic myeloid leukemia by Ahmed N Buzaid, Ali M Al-Amri

Subjects: “…Chronic myelogenous leukemia…”
Get full text

HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Leukemia by Farideh Khosravi, Aliakbar Amirzargar, Abdolfatah Sarafnejad, Mohammad Hossein Nicknam, Kamran Alimoghadam, Saied Dianat, Ghasem Solgi, Behrouz Nikbin

Subjects: Get full text

Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells by Thaís Oliveira, Douglas Lemos, Louise Jean, Jéssica M. Kawashima, Vitória R. de Azevedo, Eduardo J. Salustiano, Vivian M. Rumjanek, Robson Q. Monteiro

Subjects: Get full text

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines by Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, Zhu X

Subjects: “…Chronic myelogenous leukemia…”
Get full text

Flowcytometric evaluation of cell cycle regulators (cyclins and cyclin dependent kinase inhibitors) expressed on bone marrow cells of patients with chronic myelogenous leukemia and multiple myeloma by Selami Koçak Toprak, Klara Dalva, Merih Kızıl Çakar, Nazmiye Kurşun, Meral Beksaç

Get full text

Chronic myelogenous leukemia: the present and the future of the TKI therapy Leucemia mieloide crônica: o presente e o futuro dos inibidores de tirosino quinase by Giuseppe Saglio, Carmen Fava

Get full text

Correlation analysis of bone marrow microvessel density and miRNA expression on drug resistance in patients with chronic myelogenous leukemia after tyrosine kinase inhibitor treatment by Yi-gang Guo, Lu-lu Zhang, Ping Hu, Zhang-zhi Li, Rui-bo Zhang, Xi Lv, Qiong Yi, Ling-bo Zhan, Xue-lian Feng

Subjects: Get full text

A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13) by Surachit Kumar, Mariya Apostolova, Paul V. Woolley

“…The management of chronic myelogenous leukemia during pregnancy requires balancing the well-being of the mother with that of the fetus. …”
Get full text

Embryonic Program Activated during Blast Crisis of Chronic Myelogenous Leukemia (CML) Implicates a TCF7L2 and MYC Cooperative Chromatin Binding by Christophe Desterke, Patricia Hugues, Jin Wook Hwang, Annelise Bennaceur-Griscelli, Ali G. Turhan

Subjects: “…chronic myelogenous leukemia…”
Get full text

Integrated Chemical Characterization, Network Pharmacology and Transcriptomics to Explore the Mechanism of Sesquiterpenoids Isolated from <i>Gynura divaricata</i> (L.) DC. against Chronic Myelogenous Leukemia by Xinyuan Ye, Long Wang, Xin Yang, Jie Yang, Jie Zhou, Cai Lan, Fahsai Kantawong, Warunee Kumsaiyai, Jianming Wu, Jing Zeng

Subjects: Get full text

Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety by Mehlika Dilek Altıntop, Halil Ibrahim Ciftci, Mohamed O. Radwan, Belgin Sever, Zafer Asım Kaplancıklı, Taha F. S. Ali, Ryoko Koga, Mikako Fujita, Masami Otsuka, Ahmet Özdemir

“…In an attempt to develop potent antitumor agents, new 1,3,4-thiadiazole derivatives were synthesized and evaluated for their cytotoxic effects on multiple human cancer cell lines, including the K562 chronic myelogenous leukemia cell line that expresses the Bcr-Abl tyrosine kinase. …”
Get full text

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia by Dawne N. Shelton, Prasanthi Bhagavatula, Nathan Sepulveda, Lan Beppu, Shital Gandhi, Dahui Qin, Scott Hauenstein, Jerald Radich

“…Chronic myelogenous leukemia (CML) is a hematopoietic stem cell malignancy that accounts for 15–20% of all cases of leukemia. …”
Get full text